options for up-front therapy in egfr-mutant nsclc
Published 7 years ago • 127 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
5:47
egfr tkis for upfront treatment of nsclc
-
4:41
upfront egfr-targeted therapy for nsclc
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
16:30
up-front treatment in egfr wild-type patients
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
14:30
adjuvant therapy for egfr mutant nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
0:58
dr. papadimitrakopoulou on treatment options for egfr-mutant nsclc
-
4:26
combinations and other options for acquired resistance in egfr mutation-positive nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
9:01
emerging options for treatment of egfr-positive nsclc
-
2:02
evolutions in the treatment of egfr-mutated nsclc
-
5:02
addition of bevacizumab to up-front therapy for egfr nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer